EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists

Giuseppe Broggi, Giuseppe Angelico, Jessica Farina, Giordana Tinnirello, Valeria Barresi, Magda Zanelli, Andrea Palicelli, Francesco Certo, Giuseppe Barbagallo, Gaetano Magro, Rosario Caltabiano

Pathology - Research and Practice · 2024

DOI: 10.1016/j.prp.2024.155144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2024. Verfasst von Giuseppe Broggi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Ita…. Hauptthemen laut MEDLINE: Glioblastoma. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although novel knowledge has been acquired on the molecular landscape of glioblastoma (GBM), a relatively few steps forward have been made regarding its therapy. With the increasing use of novel immunotherapeutic drugs capable of stimulating the antitumor inflammatory response, in the last decades numerous studies aimed to characterize the tumor-associated microenvironment (TME) and its relationship with the immunogenicity of GBM. In this regard, although the tumor-associated microglia and macrophages (TAMs) and PD-L1/PD-1 axis have been emerged as one of the most relevant components of the GBM TME and one of the potential molecular pathways targetable with immunotherapy, respectively. It has been supposed that TAMs may acquire different phenotypes, switching from M1 to M2 phenotypes, with tumor-suppressive and tumor-stimulating role depending on the different surrounding conditions. PD-L1 is a type 1 transmembrane protein ligand expressed by T-cells, B-cells and antigen-presenting cells, with a main inhibitory checkpoint role on tumor immune regulation. While PD-L1 immunohistochemical expression has been extensively investigated in many cancers, its usefulness in the evaluation of GBM response rates to immunotherapy and its standardized evaluation by immunohistochemistry are still debated. The present review paper focuses on the current "state of the art" about the relationship between TME, PD-L1/PD-1 pathway and immunotherapy in GBM, also providing neuropathologists with an updated guide about the clinical trials conducted with PD-L1 and PD-1 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaHumansB7-H1 AntigenProgrammed Cell Death 1 ReceptorNeuropathologyImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

GBMGlioblastomaImmunotherapyPD-1PD-L1Tumor-associated microenvironment

Substanzen

B7-H1 AntigenProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Italy. Electronic address: giuseppe.broggi@gmail.com.
  • Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Anatomic Pathology, University of Catania, Catania 95123, Italy.
  • Department of Diagnostics and Public Health, Section of Anatomic Pathology, University of Verona, Verona 37134, Italy.
  • Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia 42123, Italy.
  • Department of Neurological Surgery, Policlinico "G. Rodolico-S. Marco" University Hospital, Catania 95121, Italy; Interdisciplinary Research Center on Brain Tumors Diagnosis and Treatment, University of Catania, Catania…

Zitieren

APA

Broggi, G., Angelico, G., Farina, J., Tinnirello, G., Barresi, V., Zanelli, M., Palicelli, A., Certo, F., Barbagallo, G., Magro, G., & Caltabiano, R. (2024). Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2024.155144

Vancouver

Broggi G, Angelico G, Farina J, Tinnirello G, Barresi V, Zanelli M, et al. Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists. Pathology - Research and Practice. 2024. doi:10.1016/j.prp.2024.155144

BibTeX
@article{Broggi2024,
  author = {Broggi, Giuseppe and Angelico, Giuseppe and Farina, Jessica and Tinnirello, Giordana and Barresi, Valeria and Zanelli, Magda and Palicelli, Andrea and Certo, Francesco and Barbagallo, Giuseppe and Magro, Gaetano and Caltabiano, Rosario},
  title = {Tumor-associated microenvironment, PD-L1 expression and their relationship with immunotherapy in glioblastoma, IDH-wild type: A comprehensive review with emphasis on the implications for neuropathologists},
  journal = {Pathology - Research and Practice},
  year = {2024},
  doi = {10.1016/j.prp.2024.155144}
}
Kostenlos starten →